Piritrexim

Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.

Product Specifications

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

325.37

Molecular Formula

C17H19N5O2

Notes

Research use only, not for human use.

Receptor

DHFR

CAS Number

72732-56-0

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

59121151 3x1.0μg DNA

HMGN1L2 CRISPR All-in-one AAV vector set (with saCas9)(Human)

Ask

View Details

NBP3-06536APC 0.1 mL

Mouse Monoclonal IVD Antibody (04) [Allophycocyanin]

Ask

View Details

abx333286 100 µL

MAP2K3 (pT222) Antibody

Ask

View Details

A46857-100UG 100 µg

KAT8 Antibody

Ask

View Details

CSB-DT4996 1 g

Furo[3,2-b]pyridin-7-amine- HCl

Ask

View Details

sc-407357-LAC-2 200 µL

WIPI-4 Lentiviral Activation Particles (h2)

Ask

View Details

Shopping Cart (0)

Your cart is empty

Piritrexim

Product Specifications

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

CAS Number

Available Sizes

Explore Other Products

HMGN1L2 CRISPR All-in-one AAV vector set (with saCas9)(Human)

Mouse Monoclonal IVD Antibody (04) [Allophycocyanin]

MAP2K3 (pT222) Antibody

KAT8 Antibody

Furo[3,2-b]pyridin-7-amine- HCl

WIPI-4 Lentiviral Activation Particles (h2)